Diabetes and insulin: better way than injection for diabetics to administer insulin

Diabetes and insulin: better way than injection for diabetics to administer insulin

Jan 11th 2014 | From the print edition

FACED with death, most people will do almost anything to stay alive. That is why many millions around the world either stick needles in themselves at frequent intervals to inject a hormone called insulin, or wear a device called an insulin pump that does the same thing automatically through a catheter that penetrates their skin. A body’s failure to make insulin, which regulates how cells burn glucose, their primary fuel, causes the symptoms doctors call type-1 diabetes. Until the discovery of insulin, in the 1920s, this form of diabetes was a death sentence.In principle, it might be possible for diabetics to take their insulin by mouth, as the hormone can be absorbed into the body through the walls of the small intestine. Unfortunately, insulin molecules cannot survive the acidity of the stomach, an organ they need to traverse to arrive in the intestine. But, as he describes in a paper in Biomacromolecules, Sanyog Jain of the National Institute of Pharmaceutical Education and Research, in Ajitgarh, India, thinks he has found a way around the problem—or, rather, through it.

Dr Jain’s idea is to wrap the insulin in oily droplets called liposomes, which will protect it from the stomach’s acid. He is not the first person to think of this, but previous attempts failed because packaging insulin in this way also stops the small intestine absorbing it. The really clever bit of Dr Jain’s thinking, therefore, is to coat the liposomes in their own layer of wrapping, made of folic acid, a molecule that helps pull oily molecules across the membranes of the cells that line the small intestine.

And it works—at least, in rodents. Indeed, insulin levels of diabetic rats fed Dr Jain’s liposomes remained high for longer than those of similar rats given the hormone by injection. It is early days, of course, and rats and humans are not the same. But this is an encouraging finding. If clinical trials in people show something similar, the world’s diabetics may no longer face the scourge of frequent injections or the irritation and risk of infection of an insulin pump.

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment